Literature DB >> 26937134

Molecular alterations in gastric cancer with special reference to the early-onset subtype.

Małgorzata Skierucha1, Anya Na Milne1, G Johan A Offerhaus1, Wojciech P Polkowski1, Ryszard Maciejewski1, Robert Sitarz1.   

Abstract

Currently, gastric cancer (GC) is one of the most frequently diagnosed neoplasms, with a global burden of 723000 deaths in 2012. It is the third leading cause of cancer-related death worldwide. There are numerous possible factors that stimulate the pro-carcinogenic activity of important genes. These factors include genetic susceptibility expressed in a single-nucleotide polymorphism, various acquired mutations (chromosomal instability, microsatellite instability, somatic gene mutations, epigenetic alterations) and environmental circumstances (e.g., Helicobcter pylori infection, EBV infection, diet, and smoking). Most of the aforementioned pathways overlap, and authors agree that a clear-cut pathway for GC may not exist. Thus, the categorization of carcinogenic events is complicated. Lately, it has been claimed that research on early-onset gastric carcinoma (EOGC) and hereditary GC may contribute towards unravelling some part of the mystery of the GC molecular pattern because young patients are less exposed to environmental carcinogens and because carcinogenesis in this setting may be more dependent on genetic factors. The comparison of various aspects that differ and coexist in EOGCs and conventional GCs might enable scientists to: distinguish which features in the pathway of gastric carcinogenesis are modifiable, discover specific GC markers and identify a specific target. This review provides a summary of the data published thus far concerning the molecular characteristics of GC and highlights the outstanding features of EOGC.

Entities:  

Keywords:  Chromosomal instability; Early-onset gastric cancer; Epigenetic alterations; Gastric cancer; Loss of heterozygosity; Microsatellite instability; Molecular alterations; Single-nucleotide polymorphism

Mesh:

Substances:

Year:  2016        PMID: 26937134      PMCID: PMC4768192          DOI: 10.3748/wjg.v22.i8.2460

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  200 in total

1.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

2.  Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study.

Authors:  H Medina-Franco; M J Heslin; R Cortes-Gonzalez
Journal:  Ann Surg Oncol       Date:  2000-08       Impact factor: 5.344

3.  Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells.

Authors:  N Murata-Kamiya; Y Kurashima; Y Teishikata; Y Yamahashi; Y Saito; H Higashi; H Aburatani; T Akiyama; R M Peek; T Azuma; M Hatakeyama
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

4.  Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour.

Authors:  Carla Oliveira; Joyce de Bruin; Sérgio Nabais; Marjolijn Ligtenberg; Cátia Moutinho; Fokko M Nagengast; Raquel Seruca; Han van Krieken; Fátima Carneiro
Journal:  Oncogene       Date:  2004-03-18       Impact factor: 9.867

5.  Chemoprevention of gastric cancer by celecoxib in rats.

Authors:  P J Hu; J Yu; Z R Zeng; W K Leung; H L Lin; B D Tang; A H C Bai; J J Y Sung
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 6.  Gastric cancer pathology and underlying molecular mechanisms.

Authors:  Heike I Grabsch; Patrick Tan
Journal:  Dig Surg       Date:  2013-07-18       Impact factor: 2.588

7.  IL-1B -31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers.

Authors:  R Sitarz; W W J de Leng; M Polak; F H M Morsink; O Bakker; W P Polkowski; R Maciejewski; G J A Offerhaus; A N Milne
Journal:  Virchows Arch       Date:  2008-08-08       Impact factor: 4.064

8.  FOXP3 inhibits NF-κB activity and hence COX2 expression in gastric cancer cells.

Authors:  Qiang Hao; Cun Zhang; Yuan Gao; Shuning Wang; Jialin Li; Meng Li; Xiaochang Xue; Weina Li; Wei Zhang; Yingqi Zhang
Journal:  Cell Signal       Date:  2013-12-02       Impact factor: 4.315

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  DNA copy number changes in young gastric cancer patients with special reference to chromosome 19.

Authors:  A Varis; B van Rees; M Weterman; A Ristimäki; J Offerhaus; S Knuutila
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more
  16 in total

1.  Racial/Ethnic Patterns of Young-Onset Noncardia Gastric Cancer.

Authors:  Andreana N Holowatyj; Cornelia M Ulrich; Mark A Lewis
Journal:  Cancer Prev Res (Phila)       Date:  2019-08-16

2.  Identification of a prognostic 5-Gene expression signature for gastric cancer.

Authors:  Jun-Yi Hou; Yu-Gang Wang; Shi-Jie Ma; Bing-Yin Yang; Qian-Ping Li
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-29       Impact factor: 4.553

Review 3.  Gastric cancer: epidemiology, prevention, classification, and treatment.

Authors:  Robert Sitarz; Małgorzata Skierucha; Jerzy Mielko; G Johan A Offerhaus; Ryszard Maciejewski; Wojciech P Polkowski
Journal:  Cancer Manag Res       Date:  2018-02-07       Impact factor: 3.989

Review 4.  Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype.

Authors:  Małgorzata Pucułek; Julita Machlowska; Ryszard Wierzbicki; Jacek Baj; Ryszard Maciejewski; Robert Sitarz
Journal:  Oncotarget       Date:  2018-07-24

Review 5.  Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected.

Authors:  Irina V Bure; Marina V Nemtsova
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 6.  Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology.

Authors:  Magdalena Cisło; Agata Anna Filip; George Johan Arnold Offerhaus; Bogumiła Ciseł; Karol Rawicz-Pruszyński; Małgorzata Skierucha; Wojciech Piotr Polkowski
Journal:  Oncotarget       Date:  2018-04-10

Review 7.  New therapeutic options opened by the molecular classification of gastric cancer.

Authors:  Mihaela Chivu-Economescu; Lilia Matei; Laura G Necula; Denisa L Dragu; Coralia Bleotu; Carmen C Diaconu
Journal:  World J Gastroenterol       Date:  2018-05-14       Impact factor: 5.742

Review 8.  piRNAs in Gastric Cancer: A New Approach Towards Translational Research.

Authors:  Gleyce Fonseca Cabral; Jhully Azevedo Dos Santos Pinheiro; Amanda Ferreira Vidal; Sidney Santos; Ândrea Ribeiro-Dos-Santos
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 5.923

9.  Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing.

Authors:  Marina V Nemtsova; Alexey I Kalinkin; Ekaterina B Kuznetsova; Irina V Bure; Ekaterina A Alekseeva; Igor I Bykov; Tatiana V Khorobrykh; Dmitry S Mikhaylenko; Alexander S Tanas; Sergey I Kutsev; Dmitry V Zaletaev; Vladimir V Strelnikov
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

Review 10.  Impact of proteomics investigations on gastric cancer treatment and diagnosis.

Authors:  Mohammad Rostami-Nejad; Mostafa Rezaei-Tavirani; Vahid Mansouri; Zahra Akbari; Saeed Abdi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.